The use of cannabis is associated with a decreased risk of Helicobacter Pylori infection (HPI) – a bacterial stomach infection that can be associated with abdominal pain, weight loss, and ulcers. HPI is relatively common in adults worldwide, though many people with it do not experience severe symptoms. A team of investigators from the United States and Canada assessed the … Continue reading Study: Cannabis Use History Inversely Associated with Common Stomach Infection
Subjects who consume cannabis flowers containing nearly equal percentages of THC and CBD are less likely to report experiencing either anxiety or other adverse effects, according to data published in the journal Addiction Biology. A team of investigators associated with the University of Colorado’s Anschutz Medical Campus examined the subjective effects associated with the inhalation of cannabis flowers … Continue reading Study: Use of Cannabis Flowers with Nearly Equal Ratios of THC and CBD Associated with Greater Overall Subjective Effects
The adjunctive use of CBD is associated with a reduction in patients’ use of antipsychotic medicines, according to placebo-controlled trial data published in the journal Frontiers in Psychiatry. An international team of researchers from Canada, Switzerland, and Germany assessed the use of CBD cigarettes versus placebo in a cohort of acutely psychotic patients with schizophrenia or other psychotic … Continue reading Clinical Trial: CBD Cigarettes Associated with Reductions in Antipsychotic Medications in Patients with Schizophrenia
Cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA) exhibit anti-COVID activity in culture, according to data published in the Journal of Natural Products. Researchers with the University of Oregon reported that both cannabinoids inhibited the entry of SARS-CoV-2 into human epithelial cells. Authors reported that the cannabinoid acids showed equal efficacy against multiple COVID variants. Both compounds are abundant organically in … Continue reading Cannabinoid Acids Exhibit Anti-COVID Activity in Preclinical Models
Neither the detection of THC nor its metabolites in blood or saliva is predictive of impaired performance, according to a meta-analysis of the relevant literature published in the journal Neuroscience and Behavioral Reviews. Australian researchers reviewed the results from 28 eligible studies (involving 824 participants) that assessed the relationship between THC-related biomarkers and individuals’ performance. They reported that … Continue reading Analysis: THC Concentrations in Blood, Oral Fluid Are Not Predictive of Impairment of Performance
The detection of THC in blood is not correlated with changes in simulated driving performance, according to data published in the journal JAMA Psychiatry. A team of investigators affiliated with the University of California, San Diego assessed subjects’ simulated driving performance after inhaling either low-potency (six percent), moderate-potency (13 percent), or placebo cannabis. Compared to their baseline performance, … Continue reading Study: THC Levels in Blood Not Linked with Changes in Simulated Driving Performance
Some employers are abandoning drug testing requirements as a way to attract new hires and to retain current employees, according to survey data compiled by the Manpower Group Pollsters surveyed representatives from over 45,000 employers in North America and Europe. Nine percent of respondents acknowledged that they had “eliminated job screenings or drug tests” as a way … Continue reading Survey: Nearly One-in-Ten Employers Dropping Drug Testing Requirements to Attract Workers
A growing number of Canadians who consume cannabis are obtaining it from the legal marketplace, according to data published in the journal Drug and Alcohol Dependence. Investigators affiliated with the University of Waterloo, School of Public Health Sciences surveyed nearly 5,000 Canadian adults who acknowledged having purchased cannabis flowers within the past year. Researchers reported that the percentage … Continue reading Canada: Growing Percentage of Cannabis Consumers Transitioning to the Licit Marketplace
Patients diagnosed with chronic pain who use medical cannabis products under a doctor’s authorization significantly decrease their use of opioids and benzodiazepines, according to data published in the journal Cannabis and Cannabinoid Research. A team of researchers with the Rothman Orthopedic Institute at Thomas Jefferson University assessed prescription drug use patterns in a cohort of pain patients prior … Continue reading Study: Chronic Pain Patients Significantly Reduce Their Use of Opioids, Benzodiazepines Following Initiation of Cannabis Therapy
The use of cannabis products is associated with a reduction in pain patients’ daily consumption of opioids, according to data published in the journal Pain Physician. A team of investigators affiliated with the Institute for Pain Medicine in Pennsylvania assessed opioid use trends in a cohort of 115 chronic pain patients who initiated medical cannabis therapy. Patients in the study … Continue reading Study: Medical Cannabis Treatment Reduces Daily Morphine Intake in Chronic Pain Patients
DonnyFerguson.com 